SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?


To: Kimberly Lee who wrote (35224)11/30/1999 12:03:00 PM
From: Tassi  Respond to of 108040
 
MEDCARE TECHNOLOGIES SIGNS AGREEMENT WITH SIGNETRUST

--------------------------------------------------------------------------------


OAK BROOK, IL.--(BUSINESS WIRE)--Nov. 30, 1999--MedCare
Technologies, Inc. (NASDAQ: MCAR.O) announced today that it has reached
an agreement with SIGNETRUST, Inc., to provide medical
credential-enhanced digital certificates to physicians via the
Company's online business RxSheets.com.
"We are pleased to be a future trusted provider of digital
certificates for MedCare's RxSheets.com internet product," said Andrew
C. Herlands, President of SIGNETRUST. "RxSheets.com promises to change
the way the pharmaceutical industry interacts with every physician in
the country."
"This is a valuable technology enabling us the ability to provide
another level of added assurance that only approved healthcare
providers have access to the countless number of services available
through our web site," said Jeff Aronin, President and Chief Executive
Officer. "We are pleased to be working with SIGNETRUST in this new
exciting and unique Internet product - - RxSheets.com."
RxSheets.com (www.rxsheets.com) has received overwhelming
response from physicians throughout the country. MedCare Technologies
launched its pharmaceutical focused site for physicians in October and
began its' marketing campaign on November 15th. During the first five
days, the Company received thousands of physician requests to enroll
in its program.
Exclusively designed for the physician, RxSheets.com offers a
wide array of compelling and focused information and services,
including drug sample requests, drug protocols and studies, research
information and other pertinent aspects of the pharmaceutical market.
The site will also offer a healthcare calendar of events, educational
opportunities and a weekly pharmaceutical newsletter.
MedCare Technologies, Inc. is a healthcare technology service
company that focuses on under-served high growth markets. The
Company's RxSheets.com (www.rxsheets.com), offers a wide array of
compelling and focused information and services, including drug sample
requests for physicians, drug protocols and studies, research
information, and other pertinent aspects of the $270 billion worldwide
pharmaceutical market. The Company began by developing the MedCare
Program, now the nations leading conservative therapy for treating
urinary incontinence, a hidden health condition that, at approximately
$26 billion, costs more than diabetes and bypass surgery combined.
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance and
underlying assumptions and other statements which are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, changes in
insurance reimbursement, economic conditions, the impact of
competition and pricing, government regulation, and other risks
defined in this document and in statements filed from time to time
with the Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on behalf
of the Company are expressly qualified by these cautionary statements
and any other cautionary statements which may accompany the
forward-looking statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect events
or circumstances after the date hereof.

--30--ajg/in*

CONTACT: MedCare Technologies, Inc.
Bruce Byots, 630/472-5306
or
MedCare Technologies, Inc.
Bill Mann, 800/611-3388
Website: www.medcareonline.com

KEYWORD: ILLINOIS
INDUSTRY KEYWORD: PHARMACEUTICAL INTERNET

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com

Copyright 1999, Business Wire





To: Kimberly Lee who wrote (35224)11/30/1999 12:12:00 PM
From: Jay k.  Respond to of 108040
 
Kim have you noticed the movement on SMRA lately?
I know you picked some up at 13 and change. Do we hold? Thanks.



To: Kimberly Lee who wrote (35224)11/30/1999 12:19:00 PM
From: Penny Stock Trader  Read Replies (1) | Respond to of 108040
 
Ok dumb question...what do you mean "let it run" in reference to QNTS. How do they hold it down.
Thanks for the info.

-PST



To: Kimberly Lee who wrote (35224)11/30/1999 12:22:00 PM
From: Kimberly Lee  Respond to of 108040
 
Today's 1st pick, IGLD, profitable Isareli ISP. buying 12 to 1/2. SIFY, KOREA, IJII and the other foreign ISPs are all running hot, IGLD is a logical sequel.



To: Kimberly Lee who wrote (35224)11/30/1999 12:22:00 PM
From: Kimberly Lee  Read Replies (2) | Respond to of 108040
 
Today's 1st pick, IGLD, profitable Isareli ISP. buying 12 to 1/2. SIFY, KOREA, IJII and the other foreign ISPs are all running hot, IGLD is a logical sequel.



To: Kimberly Lee who wrote (35224)11/30/1999 12:25:00 PM
From: Kimberly Lee  Read Replies (5) | Respond to of 108040
 
More about IGLD, 1st target 20. heard news with MSFT tomorrow. Even without the MSFT news, IGLD is a compelling buy here because of the foreign ISP theme (SIFY, KOREA, IIJI); moreover, the chart looks fairly strong